Literature DB >> 12107373

Angiotensinogen, adipocyte differentiation and fat mass enlargement.

Gérard Ailhaud1, Michèle Teboul, Florence Massiera.   

Abstract

PURPOSE OF REVIEW: Angiotensinogen and components of the renin-angiotensin system are expressed in adipose tissue of rodents and humans, but the role of generated angiotensin II has remained intriguing. Moreover, the functional importance of angiotensin II receptor subtypes in preadipocytes and adipocytes still remains a controversial subject. RECENT
FINDINGS: Recent findings in transgenic mice have emphasized the upregulation of angiotensinogen expression by glucocorticoids. Furthermore, angiotensinogen products, that is angiotensin II and possibly angiotensin II-related products, have been found to act locally in modulating adipose tissue growth in an autocrine/paracrine manner. Cellularity measurements show that fat mass enlargement is associated with adipocyte hypertrophy, consistent with the upregulation of the fatty acid synthetase gene by angiotensin II depicted at the molecular level. Together, these findings suggest a mechanism by which transient or chronic overexpression of angiotensinogen in adipose tissue favors lipogenesis in adipocytes and leads to a 'vicious' circle whereby adipose tissue development is further increased.
SUMMARY: Additional studies are warranted to characterize angiotensin II-related receptors, if any, and to clarify the role played by angiotensin II receptor subtypes and metabolites in various metabolic aspects of white adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12107373     DOI: 10.1097/00075197-200207000-00006

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  7 in total

1.  Role of transcription factor NFAT in glucose and insulin homeostasis.

Authors:  Teddy T C Yang; Hee Yun Suk; Xiaoyong Yang; Opeyemi Olabisi; Raymond Y L Yu; Jorge Durand; Linda A Jelicks; Ja-Young Kim; Philipp E Scherer; Yuhua Wang; Yun Feng; Luciano Rossetti; Isabella A Graef; Gerald R Crabtree; Chi-Wing Chow
Journal:  Mol Cell Biol       Date:  2006-08-14       Impact factor: 4.272

2.  Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice.

Authors:  Hiroaki Masuzaki; Hiroshi Yamamoto; Christopher J Kenyon; Joel K Elmquist; Nicholas M Morton; Janice M Paterson; Hiroshi Shinyama; Matthew G F Sharp; Stewart Fleming; John J Mullins; Jonathan R Seckl; Jeffrey S Flier
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

3.  Changes in gene expression foreshadow diet-induced obesity in genetically identical mice.

Authors:  Robert A Koza; Larissa Nikonova; Jessica Hogan; Jong-Seop Rim; Tamra Mendoza; Christopher Faulk; Jihad Skaf; Leslie P Kozak
Journal:  PLoS Genet       Date:  2006-05-26       Impact factor: 5.917

4.  Early pharmacological inhibition of angiotensin-I converting enzyme activity induces obesity in adulthood.

Authors:  Kely de Picoli Souza; Elton D da Silva; Elice C Batista; Felipe C G Reis; Sylvia M A Silva; Charlles H M Castro; Jaqueline Luz; Jorge L Pesquero; Edson L Dos Santos; João B Pesquero
Journal:  Front Pharmacol       Date:  2015-04-14       Impact factor: 5.810

5.  De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis.

Authors:  Mohamed Sabry Hamza; Sebastian Pott; Vinsensius B Vega; Jane S Thomsen; Gopalan Srinivasan Kandhadayar; Patrick Wei Pern Ng; Kuo Ping Chiu; Sven Pettersson; Chia Lin Wei; Yijun Ruan; Edison T Liu
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

6.  Angiotensinogen gene silencing reduces markers of lipid accumulation and inflammation in cultured adipocytes.

Authors:  Wenting X Carroll; Nishan S Kalupahana; Suzanne L Booker; Nalin Siriwardhana; Monique Lemieux; Arnold M Saxton; Naima Moustaid-Moussa
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-11       Impact factor: 5.555

7.  Increased total Renin levels but not Angiotensin-converting enzyme activity in obese patients with polycystic ovary syndrome.

Authors:  Ziynet Alphan; Zehra Berberoglu; Suheyla Gorar; Zehra Candan; Aynur Aktas; Yalcin Aral; Esranur Ademoglu
Journal:  Med Princ Pract       Date:  2013-07-26       Impact factor: 1.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.